Cipla receives final USFDA approval for generic version of Shire’s Firazyr
Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application...
Merck Opens its Largest M Lab Collaboration Center in Shanghai
Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai,...
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement
Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and...
ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution
Powder containment and sterile transfer solutions experts, ChargePoint Technology, announced that it has entered into...
Biocon’s Breakthrough Drug Itolizumab Receives DCGI Nod for its Use in Moderate to Severe...
Biocon Ltd., an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller...
“CARGY”, the new digital solution partner by Turkish Cargo
Providing air cargo service to 127 countries worldwide, Turkish Cargo’s “CARGY”, the new artificial intelligence...
AbbVie : FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with...
Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application...
Aigenpulse introduces novel data intelligence platform to life science markets
Life science and data technology innovator, Aigenpulse,is introducing a new state of-the-art data intelligence platform...
Vetter Further Expands its Development Service with New Site in Austria
With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert...
AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer
AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in...
